314 related articles for article (PubMed ID: 16616187)
1. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
Iyer S; Scotney PD; Nash AD; Ravi Acharya K
J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187
[TBL] [Abstract][Full Text] [Related]
2. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
Horta BA; Sodero AC; de Alencastro RB
J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
[TBL] [Abstract][Full Text] [Related]
3. The comparison of VEGFR-1-binding domain of VEGF-A with modelled VEGF-C sheds light on receptor specificity.
Kasap M; Sazci A
J Theor Biol; 2008 Aug; 253(3):446-51. PubMed ID: 18479712
[TBL] [Abstract][Full Text] [Related]
4. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragment.
Leonard P; Scotney PD; Jabeen T; Iyer S; Fabri LJ; Nash AD; Acharya KR
J Mol Biol; 2008 Dec; 384(5):1203-17. PubMed ID: 18930733
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.
Starovasnik MA; Christinger HW; Wiesmann C; Champe MA; de Vos AM; Skelton NJ
J Mol Biol; 1999 Oct; 293(3):531-44. PubMed ID: 10543948
[TBL] [Abstract][Full Text] [Related]
8. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
[TBL] [Abstract][Full Text] [Related]
9. The C-terminus of viral vascular endothelial growth factor-E partially blocks binding to VEGF receptor-1.
Inder MK; Wise LM; Fleming SB; Mercer AA
FEBS J; 2008 Jan; 275(1):207-17. PubMed ID: 18076652
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis.
Shibuya M
Angiogenesis; 2006; 9(4):225-30; discussion 231. PubMed ID: 17109193
[TBL] [Abstract][Full Text] [Related]
11. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
Chen WS; Kitson RP; Goldfarb RH
In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
[TBL] [Abstract][Full Text] [Related]
12. Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region.
Fujisawa D; Yamazaki Y; Lomonte B; Morita T
Biochem J; 2008 May; 411(3):515-22. PubMed ID: 18251716
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
14. Parapoxvirus of red deer in New Zealand encodes a variant of viral vascular endothelial growth factor.
Ueda N; Inder MK; Wise LM; Fleming SB; Mercer AA
Virus Res; 2007 Mar; 124(1-2):50-8. PubMed ID: 17109982
[TBL] [Abstract][Full Text] [Related]
15. Crystallization of the receptor binding domain of vascular endothelial growth factor.
Christinger HW; Muller YA; Berleau LT; Keyt BA; Cunningham BC; Ferrara N; de Vos AM
Proteins; 1996 Nov; 26(3):353-7. PubMed ID: 8953654
[TBL] [Abstract][Full Text] [Related]
16. Role of VEGF family members and receptors in coronary vessel formation.
Tomanek RJ; Holifield JS; Reiter RS; Sandra A; Lin JJ
Dev Dyn; 2002 Nov; 225(3):233-40. PubMed ID: 12412005
[TBL] [Abstract][Full Text] [Related]
17. Purification and refolding of vascular endothelial growth factor-B.
Scrofani SD; Fabri LJ; Xu P; Maccarone P; Nash AD
Protein Sci; 2000 Oct; 9(10):2018-25. PubMed ID: 11106176
[TBL] [Abstract][Full Text] [Related]
18. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
19. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
Takahashi H; Shibuya M
Clin Sci (Lond); 2005 Sep; 109(3):227-41. PubMed ID: 16104843
[TBL] [Abstract][Full Text] [Related]
20. The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding.
Davydova N; Roufail S; Streltsov VA; Stacker SA; Achen MG
J Mol Biol; 2011 Apr; 407(4):581-93. PubMed ID: 21315726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
